Cancer Research UK logo.
SearchDonate
  • Search

A trial of two treatments for vulval intraepithelial neoplasia (RT3 VIN)

Overview

Cancer types:

Vulval cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at 2 drugs called cidofovir and imiquimod for vulval intraepithelial neoplasia. The trial was supported by Cancer Research UK.

Vulval intraepithelial neoplasia (VIN) means there are abnormal cells in the skin of the . It is not cancer, but if it isn’t treated it can develop into vulval cancer. There are 3 categories of VIN. This trial recruited women with VIN 3, which means the cells are very abnormal. Your doctor may also call this severe dysplasia.

Recruitment start: 1 October 2009

Recruitment end: 25 January 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Amanda Tristram

Supported by

Cancer Research UK

Cardiff University

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Wales Cancer Trials Unit

Other information

This is Cancer Research UK trial number CRUK/06/024.

Last reviewed: 4 November 2015

CRUK internal database number: 816

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.